Ultima Genomics has appointed Chris Seipert as Senior Vice President of Operations to lead the Company's instrumentation and consumables production efforts, and Lara Toerien as Vice President of Sales, North America to drive commercial adoption across the region.
Who to call at Ultima Genomics, and when
A new leader at Ultima Genomics brings new priorities and often new vendors. The first weeks are when they listen.
An alert the day Ultima Genomics raises, hires an executive or expands, scored against what you sell
The decision-makers there, with verified emails
Who you already know at Ultima Genomics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ultima Genomics. With Fundz connected, it knows.
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Company Information
Company
Ultima Genomics
Location
Fremont, California, United States
About
Ultima Genomics is unleashing the power of genomics at scale. The Company's mission is to continuously drive the scale of genomic information to enable unprecedented advances in biology and improvements in human health. With humanity on the cusp of a biological revolution, there is a virtually endless need for more genomic information to address biology's complexity and dynamic change—and a further need to challenge conventional next-generation sequencing technologies. Ultima's revolutionary new sequencing architecture drives down the costs of sequencing to help overcome the tradeoffs that scientists and clinicians are forced to make between the breadth, depth and frequency with which they use genomic information. The new sequencing architecture was designed to scale far beyond conventional sequencing technologies, lower the cost of genomic information and catalyze the next phase of genomics in the 21st century.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ultima Genomics changes its leadership, hires an exec or expands, usually minutes after it happens, and tells you who to reach.